As it continues to bulk up its casino empire, MGM Resorts International (NYSE:MGM) has signed on a team of K&L Gates partners to lobby Congress on Native American gaming license issues, according to a government filing. The casino and hotel giant has tapped K&L Gates's public policy and law partner William A. Kirk, government affairs counselor Tricia K.Markwood and partner Bart Gordon, who formerly served 26 years in the U.S. House of Representatives for Tennessee, according to a lobbying registration document filed Thursday. MGM Resorts International (NYSE:MGM) in last trading activity decreased -2.95% to close at $20.76. Company weekly performance is -6.19% while its quarterly performance stands at -19.16%. MGM Resorts International (NYSE:MGM) is -27.79% away from its 52 week high.RF Micro Devices Inc. (NASDAQ:RFMD) on Sept. 22 unveiled 11 new amplifiers of which six are gallium nitride- (GaN-) based products to support the requirements of the new data over cable service interface specification (DOCSIS) 3.1. On last trading day RF Micro Devices Inc. (NASDAQ:RFMD) decreased -6.96% to close at $9.62. Its volatility for the week is 7.00% while volatility for the month is 4.55%. RFMD's sales growth for past 5 years was 5.30% and its EPS growth for past 5 years was 15.00%. RF Micro Devices Inc. (NASDAQ:RFMD) monthly performance is -21.72%.JPMorgan Chase & Co. (NYSE:JPM), the third-biggest Heloc originator, had a 45 percent increase in the loans in the first six months of the year, Inside Mortgage Finance data show. Some of the demand is coming from borrowers who originally took out a Heloc 10 years ago and are nearing the end of their opportunity to draw on it, so they want to refinance the line of credit, said Jim Manelis, a home equity executive at the New York-based lender. Home renovations are the No. 1 use for Heloc funds, followed by debt consolidation, he said. On last trading day JPMorgan Chase & Co. (NYSE:JPM) decreased -0.95% to close at $58.52. Its volatility for the week is 1.87% while volatility for the month is 1.43%. JPM's sales growth for past 5 years was -6.20% and its EPS growth for past 5 years was 40.00%. JPMorgan Chase & Co. (NYSE:JPM) monthly performance is -1.42%.Federal health officials have approved a daily pill that can cure the most common form of hepatitis C without the grueling pill-and-injection cocktail long used to treat the virus. But the drug’s $1,125-per-pill price is sure to increase criticism of drugmaker Gilead Sciences Inc. (NASDAQ:GILD), whose pricing strategy for an older hepatitis drug has already drawn scorn from patient groups, insurers and politicians worldwide. The Food and Drug Administration said Friday it cleared Gilead Sciences Inc. (NASDAQ:GILD)’s Harvoni combination pill for patients with genotype 1 of hepatitis C, a form of the liver-destroying virus that accounts for 70 percent of the estimated 3.2 million cases in the U.S. On Friday shares of Gilead Sciences Inc. (NASDAQ:GILD) closed at $103.73. Company's sales growth for last 5 years was 16.00% and EPS growth for next 5 years is recorded as 23.00%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
